LUNG Stock Analysis: Buy, Sell, or Hold?
LUNG - Pulmonx Corporation Common Stock
$1.63
-0.01 (-0.61%)
▼
5d:
-8.94%
30d:
-26.24%
90d:
-7.39%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 18, 2026
14d
Get Alerted When LUNG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LUNG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LUNG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LUNG is currently trading at $1.63, which is considered oversold relative to its 30-day fair value range of $1.75 to $2.20.
Technical Outlook: Technically, LUNG is in a uptrend. The price is currently testing key support at $1.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LUNG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Implied Volatility is high (84th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $5.75 (+252.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LUNG is in a uptrend. The price is currently testing key support at $1.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LUNG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Implied Volatility is high (84th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $5.75 (+252.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.75 -
$2.20
Company Quality Score
48/100
(HOLD)
Options IV Signal
84th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 84th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 252.8% below Wall St target ($5.75)
- CAUTION: 5-day price weakness (-8.9%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.75 -
$2.20
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.55
(33.9%)
Support & Resistance Levels
Support Level
$1.62
Resistance Level
$1.96
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.22
Wall Street Target
$5.75
(+252.8%)
Revenue Growth (YoY)
5.5%
Profit Margin
-61.9%
Last updated: February 02, 2026 11:56 PM ET
Data refreshes hourly during market hours. Next update: 12:56 AM
Data refreshes hourly during market hours. Next update: 12:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUNG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Geoffrey Beran Rose
SELL
6543 shares
2025-09-02
Mehul Joshi
SELL
7936 shares
2025-09-02
Steven S Williamson
SELL
9648 shares
2025-09-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 66 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 57 HOLD |
